None
Quote | InfuSystems Holdings Inc. (NYSE:INFU)
Last: | $7.74 |
---|---|
Change Percent: | 0.37% |
Open: | $8.17 |
Close: | $7.74 |
High: | $8.38 |
Low: | $7.7 |
Volume: | 46,973 |
Last Trade Date Time: | 04/22/2024 03:00:00 am |
News | InfuSystems Holdings Inc. (NYSE:INFU)
2024-04-03 06:46:43 ET More on InfuSystem InfuSystem Holdings: 2024 Will Be A Year Of Monetization InfuSystem GAAP EPS of $0.00 in-line, revenue of $31.77M beats by $1.77M Read the full article on Seeking Alpha For further details see: InfuSystem gets non...
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that the Company has re...
Message Board Posts | InfuSystems Holdings Inc. (NYSE:INFU)
Subject | By | Source | When |
---|---|---|---|
News: $INFU InfuSystem to Present at the LD | whytestocks | investorshub | 05/22/2019 6:30:39 PM |
News: $INFU InfuSystem Holdings, Inc. Reports First Quarter | whytestocks | investorshub | 05/14/2019 7:20:37 PM |
Multiple valuation analyses imply InfuSystem $INFU is highly | ValueInvestor15 | investorshub | 03/21/2017 10:03:46 AM |
Lawsuits after the bell. Five year low is | willlbone | investorshub | 11/07/2016 10:40:26 PM |
Who put the F U in INFU? | willlbone | investorshub | 11/07/2016 8:49:05 PM |
News, Short Squeeze, Breakout and More Instantly...
InfuSystems Holdings Inc. Company Name:
INFU Stock Symbol:
NYSE Market:
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that the Company has re...
2024-03-23 13:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Full Year 2023 vs. Full Year 2022: Record Net Revenues: $125.8 million, a 14% increase Patient Services Revenue: $76.5 million - Device Solutions Revenue: $49.2 million, increases of 11% and 20% Adjusted EBITDA (non-GAAP): $22.4 million, an 8% increase Fi...